Objective(s): Human umbilical cord mesenchymal stem cells (HUC-MSCs) are pluripotent stem cells with anti-inflammatory and immunomodulatory properties used in the treatment of acute lung injury (ALI). However, the treatment of ALI using exosomes derived from HUC-MSCs (HUC-MSCexos) primed with interferon-gamma (IFN-gamma-exos) has not been described. This study investigated the effects of IFN-gamma-exos on ALI. Materials and Methods: IFN-gamma primed and unprimed HUC-MSC-exos (IFN-gamma-exos and CONexos, respectively) were extracted, identified, and traced. A549 cells and mice subjected to lipopolysaccharide (LPS)-induced inflammation were treated with IFN-gamma-exos or CON-exos. Viability; interleukin (IL)-1 beta, IL-6, tumor necrosis factor (TNF)-alpha, and reactive oxygen species (ROS) levels; NF-KB p65, and NLRP3 expression and histology and lung injury scores were measured in cell, supernatant or lung tissue. Results: Indoleamine 2,3-dioxygenase (IDO) mRNA expression was elevated in HUC-MSCs primed with 5 ng/mL IFN-gamma (P<0.001), and IFN-gamma-exos and CON-exos were successfully extracted. LPSinduced inflammation resulted in decreased cell viability in A549 cells, and increased IL-1 beta, IL 6, TNF-alpha and ROS levels and NF-KB p65 and NLRP3 expression in A549 cells and mice(P<0.05 to P<0.001). Treatment with IFN-gamma-exos and CON-exos increased cell viability and decreased the concentrations of IL-1 beta, and ROS, expression of NF-KB p65 and NLRP3, and the lung injury score, and these effects were more obvious for IFN-gamma-exos(P<0.05 to P<0.001). Conclusion: IFN-gamma-exos reduced oxidative stress and inflammatory responses in LPS-induced A549 cells and mice. The result demonstrated the therapeutic potential of IFN-gamma-exos in LPS-induced ALI.